New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
I-Mab
IMAB
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

96M

Biotechnology

1.18USD
Shape-0.05 ( -4.07%)
favorite-chart

Relative Strenght

19
favorite-chart

Volume Buzz

72%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

53%

Quote Panel

Shape
Updated October 25, 2024
1W -14.49 % 1M 6.31 % 3M -13.24 % 1Y -7.81 %

Key Metrics

Shape
  • Market Cap

    95.96M


  • Shares Outstanding

    81.32M


  • Share in Float

    81.10M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    1.18


  • Average Volume

    327429


  • Beta

    1.071


  • Range

    0.99-2.536


  • Industry

    Biotechnology


  • Website

    https://www.i-mabbiopharma.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

85.53x

P/S Ratio

0.40x

P/B Ratio

0.0

Debt/Equity

-6126.8%

Net Margin

$-2.3

EPS

How IMAB compares to sector?

P/E Ratio

Relative Strength

Shape

IMAB

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$5M

ShapeNaN%

2025-Revenue

$2.03

Shape-190%

2025-EPS

$2M

Shape98%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-1.23
vs -1.24

Q4.22

arrow
arrow

N/A

-1.29
vs -1.26

Q1.23

arrow
arrow

N/A

-0.68
vs -1.00

Q2.23

arrow
arrow

N/A

-0.64
vs -0.95

Q3.23

arrow
arrow

N/A

-0.57
vs -1.23

Q4.23

arrow
arrow

N/A

-0.59
vs -1.29

Q1.24

arrow
arrow

+105%

0.04
vs -0.68

Q2.24

arrow
arrow

N/A

-0.07
vs -0.64

Q3.24

arrow
arrow

N/A

-3.36
vs -0.57

Q4.24

arrow
arrow

+1602%

8.82
vs -0.59

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+192%

25.9M  vs 8.9M

Q3.22

arrow
arrow

-489%

-136710500.00  vs 35.1M

Q4.22

arrow
arrow

-489%

-136710500.00  vs 35.1M

Q1.23

arrow
arrow

-62%

9.8M  vs 25.9M

Q2.23

arrow
arrow

-62%

9.8M  vs 25.9M

Q3.23

arrow
arrow

+103%

4M  vs -136710500

Q4.23

arrow
arrow

+103%

4M  vs -136710500

Q1.24

arrow
arrow

-100%

NA  vs 9.8M

Q2.24

arrow
arrow

-100%

NA  vs 9.8M

Q4.24

arrow
arrow

+23865%

957.3M  vs 4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-25%

-0.25
vs -0.13

Q4.22

arrow
arrow

-24%

-0.24
vs -0.25

Q1.23

arrow
arrow

-16%

-0.16
vs -0.24

Q2.23

arrow
arrow

-16%

-0.16
vs -0.16

Q3.23

arrow
arrow

-20%

-0.20
vs -0.16

Q4.23

arrow
arrow

-20%

-0.20
vs -0.20

Q1.24

arrow
arrow

NA

NA
vs -0.20

Q2.24

arrow
arrow

+11%

0.11
vs NA

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

72

72
vs 100

-28%

Q4.22

arrow
arrow

67

67
vs 72

-7%

Q1.23

arrow
arrow

54

54
vs 67

-19%

Q2.23

arrow
arrow

48

48
vs 54

-11%

Q3.23

arrow
arrow

49

49
vs 48

2%

Q4.23

arrow
arrow

45

45
vs 49

-8%

Q1.24

arrow
arrow

39

39
vs 45

-13%

Q2.24

arrow
arrow

37

37
vs 39

-5%

Earnings Growth

Latest News